ARIAD Pharma (ARIA) to Cut HQ Workforce by ~25%
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/20/2026
- US stock futures steady after tech slump; investors focus on Middle East tensions
- U.S. Treasury doubles buyback operation size for long-dated bonds
- Marvell shares jump after giving Google warrants amid custom chip deal
- U.S. debt tops $40 trillion
- Nvidia credit risk gauge hits new peak as SoftBank readies record bond issue
- Marvell issues Google warrant tied to custom chip deal
- FOMC minutes from July 28-29th meeting
- US stock futures steady after tech slump; investors focus on Middle East tensions
- Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
- Marvell shares jump after giving Google warrants amid custom chip deal
ARIAD Announces Reduction in Workforce as Part of Ongoing Company-Wide Strategic Review
March 29, 2016 12:51 PM EDTApproximately 25 Percent of its Headquarter Positions to be Impacted
CAMBRIDGE, Mass.--(BUSINESS WIRE)-- ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) today announced that it is reducing approximately 25 percent of its headquarter positions. The reduction includes approximately 90 positions in the U.S. and Europe. No customer-facing positions within ARIADs commercial or medical affairs organizations are included in this action.
This reduction in workforce is one of five key areas of ARIADs ongoing strategic review. In addition to the decision announced today, the review also includes an evaluation of commercial maximization... More
